Pazopanib in Metastatic Renal Cancer: A “Real-World” Experience at National Cancer Institute “Fondazione G. Pascale”

Pazopanib is an oral angiogenesis inhibitor, currently approved for treatment of metastatic renal cell carcinoma (mRCC) and soft tissue sarcoma. The present study analyzed the outcomes of pazopanib in first-line treatment of mRCC, in a single Italian cancer center. In the light of the retrospective,...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Front Pharmacol
Main Authors: Cecere, Sabrina C., Rossetti, Sabrina, Cavaliere, Carla, Della Pepa, Chiara, Di Napoli, Marilena, Crispo, Anna, Iovane, Gelsomina, Piscitelli, Raffaele, Sorrentino, Domenico, Ciliberto, Gennaro, Maiolino, Piera, Muto, Paolo, Perdonà, Sisto, Berretta, Massimiliano, Pignata, Sandro, Facchini, Gaetano, D'Aniello, Carmine
Format: Artigo
Sprog:Inglês
Udgivet: Frontiers Media S.A. 2016
Fag:
Pharmacology
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5005368/
https://ncbi.nlm.nih.gov/pubmed/27630568
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2016.00287
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker